HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 186 filers reported holding HERON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $118,391 | -25.0% | 33,826 | -40.6% | 0.00% | – |
| Q1 2024 | $157,796 | +92.1% | 56,966 | +17.9% | 0.00% | – |
| Q4 2023 | $82,125 | +166.0% | 48,309 | +61.2% | 0.00% | – |
| Q3 2023 | $30,875 | -19.2% | 29,976 | -9.0% | 0.00% | – |
| Q2 2023 | $38,222 | +27.1% | 32,950 | +174.0% | 0.00% | – |
| Q4 2022 | $30,063 | -41.1% | 12,025 | -0.7% | 0.00% | – |
| Q3 2022 | $51,000 | +54.5% | 12,110 | +2.7% | 0.00% | – |
| Q2 2022 | $33,000 | -51.5% | 11,786 | -0.2% | 0.00% | – |
| Q1 2022 | $68,000 | -31.3% | 11,811 | +8.7% | 0.00% | – |
| Q4 2021 | $99,000 | -17.5% | 10,861 | -3.5% | 0.00% | – |
| Q3 2021 | $120,000 | -33.0% | 11,256 | -2.3% | 0.00% | – |
| Q2 2021 | $179,000 | -42.1% | 11,521 | -39.6% | 0.00% | -100.0% |
| Q1 2021 | $309,000 | -15.1% | 19,071 | +10.9% | 0.00% | 0.0% |
| Q4 2020 | $364,000 | +49.8% | 17,195 | +4.7% | 0.00% | 0.0% |
| Q3 2020 | $243,000 | -25.2% | 16,420 | -25.7% | 0.00% | 0.0% |
| Q2 2020 | $325,000 | – | 22,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |